General Purposes The general purposes of the Committee are to: • Develop the Company’s overall executive compensation philosophy and objectives; • Discharge the Board’s responsibilities relating to compensation of the Company’s executive officers and, further, to assist the Board in the discharge of its fiduciary responsibilities with regard to establishment of policies governing, and the implementation of, all aspects of remuneration throughout the Company, including benefits and perquisites of executive officers of the Company and any other employees designated by the Committee as key employees of the Company and its subsidiaries; • Discharge similar responsibilities with respect to the remuneration of non-employee directors; • Review and discuss with management the Company’s disclosures in the Compensation Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A should be included in the Company’s proxy statement or other applicable SEC filings; • Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings with the SEC that complies with the rules and regulations of the SEC; and • Provide policy guidance and oversight on significant human resource policies and practices. With the assistance of management and any outside advisers the Committee deems appropriate (a) review and discuss with management the Company’s disclosures in the CD&A, and, based on this review, make a recommendation as to whether to include it in the Company’s annual report on Form 10-K and proxy statement relating to the Company’s annual meeting of shareholders, and (b) prepare a Compensation Committee Report for inclusion in the Company’s proxy statement or other applicable SEC filings. 4 Board Reports and Annual Evaluation

Geon BIO materials are formulated with PolyOne’s plant-based reFlex™ 300 plasticizer, which has been tested and certified by the United States Department of Agriculture’s BioPreferred® Program to be 99 percent bio-based. In addition, specific Geon BIO healthcare formulations are pre-certified to meet biocompatibility requirements for United States Pharmacopeia (USP) Class VI protocols.

Exempt payee code These codes apply to persons submitting this form for accounts maintained outside of the United States by certain foreign financial institutions. Line 6 Enter your city, state, and ZIP code.

Code of Conduct Supplier Code of Conduct Explore our state-of-the-art Asia Innovation Center in the heart of Shanghai

United States  United States  Code of Conduct

The current state of healthcare

Through both fully accredited testing and in-house testing capabilities, our team uses state-of-the-art equipment and software to generate data for insight into material behavior, environmental effects, and more.

Through both fully accredited testing and in-house testing capabilities, our team uses state-of-the-art equipment and software to generate data for insight into material behavior, environmental effects, and more.

The acquired businesses design and produce innovative, lightweight, high-performance solutions, utilizing advanced composite technology and state-of-the-art manufacturing capabilities. SEC Filings

Patterson further stated.  SEC Filings